Avacta Group Plc - notizie pubblicate 143 - letture 5.211


Avacta Group plc

AVACTA GROUP PLC

Preliminary Results for the year ending 31 December 2020

Significant progress in diagnostics and therapeutics divisions avacta group plc (aim: avct), the developer of diagnostics and innovative cancer therapies based on its proprietary a ...

23.04.2021
Avacta Group plc

AVACTA GROUP PLC

Preliminary Results for the year ending 31 December 2020

Significant progress in diagnostics and therapeutics divisions avacta group plc (aim: avct), the developer of diagnostics and innovative cancer therapies based on its proprietary a ...

22.04.2021
Avacta Group plc

AVACTA GROUP PLC

Notice of Results and Investor Presentation

Avacta group plc (aim: avct), the developer of diagnostics and innovative cancer therapies based on its proprietary affimer® and pre|cision™ platforms, will announce its financi ...

13.04.2021
Avacta Group plc

AVACTA GROUP PLC

Distribution Agreement with ABCAM plc

Global distribution agreement with abcam plc to sell avacta's sars-cov-2 research elisa1affimer® reagents avacta group plc (aim: avct), the developer of innovative cancer therapie ...

06.04.2021
Avacta Group plc

AVACTA GROUP PLC

Life at Avacta: Interview with Carol Greenlees, Head of Clinical Operations

What attracted you to avacta? avacta's therapeutics division offers a dynamic environment to work in and has a very clear and strong sense of direction that is driven by the ambiti ...

24.03.2021
Avacta Group plc

AVACTA GROUP PLC

Commercial Partnership with Mologic

Partnership to accelerate ce marking of avacta's sars-cov-2 rapid antigen test and support covid-19 testing in low and middle income countries avacta group plc (aim: avct), the dev ...

08.02.2021
Avacta Group plc

AVACTA GROUP PLC

AffyXell $7.3 Million Series A Financing

Avacta's next generation cell and gene therapy joint venture with daewoong pharmaceutical secures series a venture funding avacta group plc (aim: avct), the developer of affimer® ...

01.02.2021
Avacta Group plc

AVACTA GROUP PLC

Collaboration Agreement with Bruker

Collaboration to evaluate the clinical utility of the high throughput bead assisted mass spectrometry (bamstm) test for sars-cov-2 infection developed with adeptrix avacta group pl ...

28.01.2021
Condividi